What Compliance Insight does

Compliance Insight is a Cincinnati-based FDA regulatory and quality compliance consulting firm founded in 2000 by Cindy Ipach. The firm provides advisory services to pharmaceutical, medical device, biologic, dietary supplement, cosmetic, and peptide companies navigating FDA regulatory processes, with a stated track record of "hundreds of projects" delivered across North America and internationally. Its service portfolio spans roughly 20 specialized offerings, including FDA 483 and Warning Letter response, US Agent and Official Correspondent services for foreign establishments, audits (mock, vendor, GXP gap, clinical trial site), regulatory affairs and submissions, quality systems, QMSR transition consulting, MoCRA compliance, Good Supply Practice, peptides compliance, product recalls, and Virtual Quality Assurance staffing.

The firm does not operate a technology platform; it delivers expert human consultancy services by a team in which each member holds at least 15 years of FDA-regulated industry experience, supported by founders and executives including President Cindy Ipach, Chief Compliance Officer Troy Fugate, CFO Rhonda Cassidy, VP Operations and Regulatory Compliance Dia Hill, and Director of Regulatory Compliance Melissa Schneider. Beyond consulting, the firm has built two recurring educational products: GXP Infusion, a six-month continuing education platform for GXP training, and the Quality Assurance Accreditation Program, a 20-week accreditation course for professionals new to pharma, devices, and biologics.

Commercially, Compliance Insight operates as a professional services firm with an enterprise field sales motion and quote-based, project-scoped pricing tailored to each engagement. It maintains Cincinnati headquarters, an East Coast office, and a North Carolina office, and distributes through direct consulting engagements supplemented by content marketing (blog, white papers, video series), webinars/virtual training, social media, and a strategic partner network that includes law firms (Greenberg Traurig, SG Law, Florida Healthcare Law Firm), Sikich, Xavier Health, and the American Peptides Society. Founder-owned and privately held, the firm shows no evidence of outside funding, acquisitions, or parent-company ownership.

Name

Compliance Insight

Legal name

Compliance Insight Inc.

Website

https://compliance-insight.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

51–100 employees

Short description

Compliance Insight is a Cincinnati-based FDA regulatory and quality compliance consulting firm serving pharmaceutical, medical device, biologic, dietary supplement, cosmetic, and peptide companies with advisory and training services across the FDA compliance lifecycle.

Ownership category

akta.pro rank

Product category

FDA Regulatory and Quality Compliance Consulting

NAICS

Management, Scientific, and Technical Consulting Services (5416), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Engineering, Accounting, Research, Management (8700)

akta.pro primary industry

Regulatory Intelligence, Labeling & Promotional Compliance (HLAGAKAN)

akta.pro secondary industries

Regulatory Compliance Advisory (BPAHAFAB), Regulatory Compliance Management (GRC, audits, reporting) (EDABADAI), Regulatory Consulting & Compliance Program Management (FDA/USDA/EFSA) (AFALADAC)

Keywords

• FDA regulatory consulting
• Quality compliance services
• Pharmaceutical regulatory affairs
• Medical device compliance
• Life sciences consulting

Headquarters

HQ city

Cincinnati

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Regulatory Compliance Consulting Services: Professional consulting services provided to FDA-regulated companies including pharmaceutical, medical device, biologics, and dietary supplement manufacturers. Services include regulatory strategy, FDA submissions, quality systems, audits, training, and compliance remediation.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Core offering

Compliance Insight is an FDA regulatory and quality compliance consulting firm that helps life science companies navigate FDA processes, achieve compliance, and develop best practices. It sells project-based consulting engagements spanning regulatory affairs, quality systems, audits, FDA 483/Warning Letter response, US Agent representation, product recalls, and QMSR transition work for pharmaceutical, medical device, biologic, dietary supplement, cosmetic, and peptide manufacturers. It also sells structured training offerings (GXP Infusion and a Quality Assurance Accreditation Program) as standalone educational products.

Product overview

Compliance Insight is an FDA regulatory and quality compliance consulting firm that offers a comprehensive suite of advisory services for life sciences companies in the pharmaceutical, medical device, biologic, and dietary supplement sectors. The company provides both core consulting services and educational products. Core consulting services include Cell & Gene Therapy Consulting, Pharmaceutical Drugs Consulting, Medical Devices Consulting, FDA 483/Warning Letter Response, US Agent & Official Correspondent, Audits, Compliance Without the Attorney Fees, Dietary Supplement Consulting, Facility Registration & Listing, FDA Compliance, Good Supply Practice, MoCRA Compliance, Quality Culture, QMSR Transition Consulting, Peptides Compliance, Product Recalls, Quality Systems, Regulatory Affairs, Training, and Virtual Quality Assurance. Educational products include GXP Infusion (a six-month continuing education platform) and the Quality Assurance Accreditation Program (a twenty-week professional training course). The company was founded in 2000 and is headquartered in Cincinnati, Ohio.

Differentiator

Problem solved

Functional benefit

Brands

• GXP Infusion: A one-of-a-kind continuing education platform offered in six-month sessions for GXP training, featuring lessons shared online in brief segments.
• Quality Assurance Accreditation Program

Products and services

• Cell & Gene Therapy Consulting FDA compliance consulting for cell and gene therapy product development and commercial production, including regulatory classification, gap analysis, GMP manufacturing plans, and regulatory submissions.
• Pharmaceutical Drugs Consulting Regulatory consulting for pharmaceutical drug development covering product and device compatibility, pharmacology assessment, FDA submissions, and international regulatory requirements.
• Medical Devices Consulting Consulting for medical device product development, validation, quality control systems, and FDA/ISO regulatory compliance for domestic and international markets.
• FDA 483 / Warning Letter Response End-to-end consulting for FDA 483 and Warning Letter response including root cause analysis, CAPA plan development, formal written response drafting, and post-response follow-up support.
• US Agent & Official Correspondent FDA U.S. Agent and Official Correspondent services for foreign establishments, including coordinating FDA communications, scheduling inspections, and maintaining electronic registration and listing.
• Audits FDA audit risk assessment and evaluative services including PAI preparation, mock audits, laboratory audits, vendor audits, GXP gap analysis, and clinical trial site audits.
• Compliance Without the Attorney Fees FDA compliance consulting services providing practical, cost-effective alternatives to legal counsel for product label review, FDA submissions, gap analysis, SOP generation, and mock audits.
• Dietary Supplement Consulting Compliance consulting for dietary supplement manufacturers covering ingredient assessment, label wording, and FDA categorization requirements.
• Facility Registration & Listing Consulting for facility registration and listing through FDA FURLS, including manufacturing facility identification, facility design and construction consultation, and equipment acceptance testing.
• FDA Compliance General FDA compliance consulting for pharmaceutical, medical device, and biologic industries covering product submission, GXP training, clinical and nonclinical development, and system monitoring.
• Good Supply Practice Supply chain compliance consulting based on the Supply-by-Design methodology developed with FDA officials, covering supplier qualification, cross-functional alignment, and supply chain risk management.
• MoCRA Compliance Modernization of Cosmetics Regulation Act compliance consulting covering regulatory strategy, labeling review, adverse event reporting systems, and FDA facility registration and product listing.
• Quality Culture Consulting services to help pharmaceutical, medical device, and biologic companies build sustainable quality cultures that manage risk and improve organizational success.
• QMSR Transition Consulting Consulting for FDA Quality Management System Regulation transition from QSR to QMSR aligned with ISO 13485:2016, including gap assessments, procedure updates, and training.
• Peptides Compliance Regulatory classification, compounding compliance (503A & 503B), label and advertising review, quality systems support, and enforcement risk strategy for peptide products.
• Product Recalls Class I, II, and III product recall management services including recall strategies, consumer notifications, market withdrawal, and product disposal.
• Quality Systems Quality assurance consulting covering quality control system design, clinical material audits, best practices implementation, policy development, and trend analysis.
• Regulatory Affairs Regulatory affairs consulting for FDA submission assistance, regulatory filings, and approval process advancement for pharmaceuticals, substances, and devices.
• Virtual Quality Assurance On-demand QA services for pharmaceutical and medical device companies fulfilling short-term or fluctuating mission-critical roles including FDA audits, change control, SOP creation, and batch record review.
• Training GCP, GMP, and GSP training programs for life science professionals covering FDA compliance, quality assurance, and good practice requirements.
• GXP Infusion Six-month continuing education platform delivering GXP training in brief online segments, replacing annual compliance presentations with ongoing workforce development.
• Quality Assurance Accreditation Program Twenty-week accreditation program for professionals new to pharmaceuticals, medical devices, and biologics, featuring weekly e-booklets, coaching sessions, and final examination.

Quantifiable outcome

• Successfully executed services on hundreds of projects around the globe
• +1 more outcomes

Named customers4 records

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Seven partnerships are on record, tiered core and minor.

• SikichcoreStrategic or Co-development PartnerTechnology and consulting firm partner listed on the Our Partners section of the website. Works within Compliance Insight's innovative network of industry professionals sharing values, vision, and commitment to excellence.
• SG LawcoreStrategic or Co-development PartnerStrategic partner listed on the Our Partners section. Works within Compliance Insight's network of industry professionals sharing values and commitment to excellence.
• Greenberg TraurigcoreStrategic or Co-development PartnerLaw firm partner listed on the Our Partners section. Works within Compliance Insight's network of industry professionals.
• American Peptides SocietycoreStrategic or Co-development PartnerIndustry association partner listed on the Our Partners section representing peptide industry professionals.
• Florida Healthcare Law FirmcoreStrategic or Co-development PartnerHealthcare law firm partner listed on the Our Partners section. Works within Compliance Insight's innovative network of industry professionals.
• Law FirmscoreImplementation/ SI/ Consulting PartnerCompliance Insight often partners with law firms on behalf of clients. This partnership frees the legal team to focus on legal aspects such as lawsuits while compliance personnel handle hands-on remediation activities. Provides end-to-end FDA 483 and Warning Letter response consulting.
• Xavier HealthminorStrategic or Co-development PartnerCompliance Insight's Good Supply Practice consultants developed the GSPs and are Xavier Health Certified Trainers. They developed workshops using tools created by FDA officials and industry experts.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• ProPharma Group: ProPharma Group provides FDA regulatory compliance, quality assurance, and validation consulting to pharmaceutical, medical device, and biotech manufacturers — directly comparable in service mix and target customer to Compliance Insight.
• Lachman Consultant Services: Lachman Consultants is a long-standing FDA regulatory and GMP compliance consulting firm serving pharmaceutical, biologic, and medical device companies, with a comparable boutique model and senior-consultant-led delivery.
• Regulatory Compliance Associates (RCA): RCA provides regulatory compliance, quality, and validation consulting for life sciences companies, with overlapping practices in FDA 483/Warning Letter response, audits, and quality systems — a close functional peer to Compliance Insight.
• The FDA Group: The FDA Group supplies FDA regulatory, quality, and compliance consultants on a project and fractional basis, closely mirroring Compliance Insight's expert-consultant delivery model and life-sciences customer base.
• BioTeknica: BioTeknica provides quality, regulatory, and compliance consulting for medical device and combination product companies, overlapping with Compliance Insight's medical-device and QMSR transition services.

Broad incumbents

• NSF (NSF Health Sciences): NSF's health-sciences division offers regulatory consulting, training, and certification across pharma, medical devices, and dietary supplements — a broader incumbent with adjacent but overlapping services to Compliance Insight.
• Charles River Laboratories: Charles River is a large CRO/CDMO that also provides regulatory and quality consulting services to pharma and device manufacturers, competing with Compliance Insight at the enterprise tier.
• IQVIA: IQVIA bundles FDA regulatory affairs and quality consulting into its broader clinical and commercial life-sciences platform, serving as a large incumbent against which Compliance Insight competes for multi-workstream engagements.
• Parexel: Parexel offers regulatory consulting and submissions services within its broader CRO portfolio, representing a larger incumbent option for life-sciences clients evaluating Compliance Insight.

Emerging players

• Greenlight Guru: Greenlight Guru provides a tech-enabled quality management system platform for medical device companies, including QMSR/ISO 13485 templates — an emerging tech-enabled alternative that could displace parts of Compliance Insight's QMSR transition and quality-systems work.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCR96AESJoRkAGLXvfuC-aKg
• Facebookfacebook.com/sharer.php?u=https://www.compliance-insight.com
• Xtwitter.com/intent/tweet?url=https://www.compliance-insight.com
• LinkedInlinkedin.com/shareArticle?url=https://www.compliance-insight.com

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Compliance Insight